A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis

Clinical trial NCT01732757 · COMPLETED

Trial details

NCT number: NCT01732757
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Conjunctivitis, Allergic

Start date: 2012-11-01
Primary completion: 2012-12-01
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.